Then, the pathway enrichment analysis was carried out, and the results showed that HCC-related DEmRNAs were enriched in biological pathways such as breast cancer, melanoma, transcriptional mis-regulation in cancer, p53 signaling pathway, cell cycle, glioma, and so on (Figure 3e). This evidence concerns the gene TP53 and cancer.